FDA Inspection 1168524 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Apr 14, 2022 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 14, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Rye, NY (United States)